Singapore markets closed
Straits Times Index
3,195.04 -18.61 (-0.58%) S&P 500
3,973.75 +72.39 (+1.86%) Dow
31,880.24 +618.34 (+1.98%) Nasdaq
11,535.27 +180.66 (+1.59%) BTC-USD
29,259.11 -1,166.19 (-3.83%) CMC Crypto 200
653.91 -20.97 (-3.11%)
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 247.50 |
| Open | 249.68 |
| Bid | 247.75 x 1100 |
| Ask | 249.36 x 900 |
| Day's range | 247.88 - 251.05 |
| 52-week range | 198.64 - 258.45 |
| Volume | |
| Avg. volume | 3,164,396 |
| Market cap | 133.037B |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | 24.61 |
| EPS (TTM) | 10.12 |
| Earnings date | 01 Aug 2022 - 05 Aug 2022 |
| Forward dividend & yield | 7.76 (3.14%) |
| Ex-dividend date | 16 May 2022 |
| 1y target est | 249.62 |
- Zacks
Novartis (NVS) Cosentyx Gets Positive CHMP Opinion for JIA
Novartis (NVS) Cosentyx gets a positive CHMP recommendation for the indication of juvenile idiopathic arthritis.
- Motley Fool
Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?
J&J's immunology mega-blockbuster loses exclusivity in the U.S. next year -- and Amgen's biosimilar is ready to capitalize.
- Zacks
Mirati (MRTX) Seeks EU Nod for Adagrasib to Treat Lung Cancer
Mirati (MRTX) seeks a nod for its lung cancer candidate adagrasib in the European Union. A regulatory filing in the United States is currently under the FDA review with decision pending this year-end.
© 2022 Yahoo. All rights reserved.
